What does PHARMACIE HUBERMONT do?

PHARMACIE HUBERMONT is a pharmacy in Sainte-Ode. Public Limited, started on 27 June 1985, 1 establishment.

What is the address of PHARMACIE HUBERMONT?

The registered office of PHARMACIE HUBERMONT is located at Rue de la Vallée de l'Ourthe 79, 6680 Sainte-Ode.

Is PHARMACIE HUBERMONT still active?

Yes. According to the CBE (17 September 2026) PHARMACIE HUBERMONT is active, legal situation “Normale toestand”, started on 27 June 1985.

Is PHARMACIE HUBERMONT registered on Peppol?

Yes, PHARMACIE HUBERMONT is registered on the Peppol network with ID 0208:0427368934.

What is the enterprise number of PHARMACIE HUBERMONT?

The enterprise number of PHARMACIE HUBERMONT is BE0427368934.

When was PHARMACIE HUBERMONT founded?

PHARMACIE HUBERMONT was founded on 27 June 1985.

Who are the directors of PHARMACIE HUBERMONT?

According to the 2025 annual accounts, the directors of PHARMACIE HUBERMONT are: François Lagneau, SRL Lagneau-Hubermont BV.

Is PHARMACIE HUBERMONT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 June 1985; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE HUBERMONT make in 2025?

PHARMACIE HUBERMONT recorded a loss after taxes of € 111,760 in financial year 2025.

What is the revenue of PHARMACIE HUBERMONT?

As a small company, PHARMACIE HUBERMONT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 286,761.

How much does an employee at PHARMACIE HUBERMONT earn?

The average wage cost per full-time employee at PHARMACIE HUBERMONT was € 60,000 in 2025: staff costs of € 113,960 for 1.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE HUBERMONT have?

According to the 2025 annual accounts, PHARMACIE HUBERMONT has 1.9 full-time equivalents (FTE).

PHARMACIE HUBERMONT (Public Limited) - Sainte-Ode

Dossier PHARMACIE HUBERMONT, printed on 17 September 2026 from databakkes.be/en/0427368934/pharmacie-hubermont. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE HUBERMONT from Sainte-Ode, company number BE0427368934, closed financial year 2025 with a result of € -111,760 after tax. For that financial year PHARMACIE HUBERMONT recorded a gross margin of € 286,761 and equity of € 14,965. Compared with financial year 2024, the result moved from € 198,211 to € -111,760. The company made a loss. The buffer shrank hard: equity is 88 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 14, 2026.

What it is worth Shrank hard

€ 14,965

▼ 88% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -111,760

▼ still € 198,211 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 631,702

▲ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -47,008.

People and assets in 2025

Full-time equivalents

1.9

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 113,960

▲ 11% vs 2024

€ 60,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,738

▼ 41% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 21 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 321,010

▼ 5% vs 2024

€ 15,563 is repaid this year. At this pace the long-term loan is gone in ≈ 21 years.

Owed to suppliers

€ 52,500

▲ 223% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 13,021

▼ 30% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 220,647 Gross margin 2022: € 220,647 First fiscal year in the series	€ 220,733 Gross margin 2023: € 220,733 Unchanged (€ 220,647) Favourable step	€ 350,347 Gross margin 2024: € 350,347 ▲ 59% vs 2023 (€ 220,733) Favourable step	€ 286,761 Gross margin 2025: € 286,761 ▼ 18% vs 2024 (€ 350,347) Unfavourable step	▼ 18%
Profit after taxes	€ 96,062 Profit after taxes 2022: € 96,062 First fiscal year in the series	€ 100,170 Profit after taxes 2023: € 100,170 ▲ 4% vs 2022 (€ 96,062) Favourable step	€ 198,211 Profit after taxes 2024: € 198,211 ▲ 98% vs 2023 (€ 100,170) Favourable step	€ -111,760 Profit after taxes 2025: € -111,760 ▼ € 309,971 vs 2024 (€ 198,211) Unfavourable step	▼ € 309,971
Equity	€ 126,444 Equity 2022: € 126,444 First fiscal year in the series	€ 126,514 Equity 2023: € 126,514 Unchanged (€ 126,444) Favourable step	€ 126,725 Equity 2024: € 126,725 Unchanged (€ 126,514) Favourable step	€ 14,965 Equity 2025: € 14,965 ▼ 88% vs 2024 (€ 126,725) Unfavourable step	▼ 88%
Total debts	€ 790,947 Total debts 2022: € 790,947 First fiscal year in the series	€ 807,939 Total debts 2023: € 807,939 ▲ 2% vs 2022 (€ 790,947) Unfavourable step	€ 975,262 Total debts 2024: € 975,262 ▲ 21% vs 2023 (€ 807,939) Unfavourable step	€ 1,238,490 Total debts 2025: € 1,238,490 ▲ 27% vs 2024 (€ 975,262) Unfavourable step	▲ 27%
Cash	€ 320,525 Cash 2022: € 320,525 First fiscal year in the series	€ 380,816 Cash 2023: € 380,816 ▲ 19% vs 2022 (€ 320,525) Favourable step	€ 534,575 Cash 2024: € 534,575 ▲ 40% vs 2023 (€ 380,816) Favourable step	€ 631,702 Cash 2025: € 631,702 ▲ 18% vs 2024 (€ 534,575) Favourable step	▲ 18%
Land & buildings	€ 372,169 Land & buildings 2022: € 372,169 First fiscal year in the series	€ 369,836 Land & buildings 2023: € 369,836 ▼ 1% vs 2022 (€ 372,169) Unchanged	€ 361,502 Land & buildings 2024: € 361,502 ▼ 2% vs 2023 (€ 369,836) Unchanged	€ 353,169 Land & buildings 2025: € 353,169 ▼ 2% vs 2024 (€ 361,502) Unchanged	▼ 2%
Retained profit	€ 64,471 Retained profit 2022: € 64,471 First fiscal year in the series	€ 64,540 Retained profit 2023: € 64,540 Unchanged (€ 64,471) Favourable step	€ 64,752 Retained profit 2024: € 64,752 Unchanged (€ 64,540) Favourable step	€ -47,008 Retained profit 2025: € -47,008 ▼ € 111,760 vs 2024 (€ 64,752) Unfavourable step	▼ € 111,760
Dividend	€ 96,000 Dividend 2022: € 96,000 First fiscal year in the series	€ 100,100 Dividend 2023: € 100,100 ▲ 4% vs 2022 (€ 96,000) Unchanged	€ 198,000 Dividend 2024: € 198,000 ▲ 98% vs 2023 (€ 100,100) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 198,000) Unchanged	▼ 100%
Bank debt	€ 365,297 Bank debt 2022: € 365,297 First fiscal year in the series	€ 350,912 Bank debt 2023: € 350,912 ▼ 4% vs 2022 (€ 365,297) Favourable step	€ 336,169 Bank debt 2024: € 336,169 ▼ 4% vs 2023 (€ 350,912) Favourable step	€ 321,010 Bank debt 2025: € 321,010 ▼ 5% vs 2024 (€ 336,169) Favourable step	▼ 5%
Balance sheet total	€ 917,391 Balance sheet total 2022: € 917,391 First fiscal year in the series	€ 934,453 Balance sheet total 2023: € 934,453 ▲ 2% vs 2022 (€ 917,391) Unchanged	€ 1,101,987 Balance sheet total 2024: € 1,101,987 ▲ 18% vs 2023 (€ 934,453) Unchanged	€ 1,253,456 Balance sheet total 2025: € 1,253,456 ▲ 14% vs 2024 (€ 1,101,987) Unchanged	▲ 14%
Employees (FTE)	1.2 Employees (FTE) 2022: 1.2 First fiscal year in the series	1.7 Employees (FTE) 2023: 1.7 ▲ 0.5 vs 2022 (1.2) Unchanged	1.9 Employees (FTE) 2024: 1.9 ▲ 0.2 vs 2023 (1.7) Unchanged	1.9 Employees (FTE) 2025: 1.9 Unchanged (1.9) Unchanged

Key figures of PHARMACIE HUBERMONT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE HUBERMONT?

What happened at PHARMACIE HUBERMONT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 14, 2026 New annual accounts for financial year 2025: loss of € 111,760 (▼ € 309,971 vs 2024). filed late Source: NBB ↗
2022 François Lagneau became a director. NBB
2022 SRL Lagneau-Hubermont BV became a director. NBB
Jul 1, 1985 New establishment in Sainte-Ode. KBO
Jun 27, 1985 Start of the company according to the CBE. KBO

In short

From € 96,062 profit in 2022 to € 111,760 loss in 2025.

Paid € 22,880 in corporate taxes since 2022.

Best year ever: 2024, with € 198,211 profit.

On average € 150,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE HUBERMONT? We notify you, reason included.

Follow PHARMACIE HUBERMONT

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

LAGNEAU-HUBERMONT 100%

The stake of LAGNEAU-HUBERMONT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE HUBERMONT

Behind PHARMACIE HUBERMONT are François Lagneau and SRL Lagneau-Hubermont BV. The shares are held by LAGNEAU-HUBERMONT (100%).

See the full network in the app

Directors

According to the 2025 annual accounts

François Lagneau

Director

Also active at: Régie communale autonome Sport pour tous en Centre-Ardenne

since 2022

SRL Lagneau-Hubermont BV

Managing director · represented by Linda Hubermont

since 2022

Shareholders

LAGNEAU-HUBERMONT

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Vallée de l'Ourthe 79

6680 Sainte-Ode

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0427.368.934

VAT number

BE 0427.368.934

Registered office

Rue de la Vallée de l'Ourthe 79, 6680 Sainte-Ode

Names & denominations

PHARMACIE HUBERMONT

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

27 June 1985

Peppol

Active · Active since 19 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE HUBERMONT

Financials

What happened to PHARMACIE HUBERMONT?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions